2-Mercaptoethanol

2-Mercaptoethanol

SCHEMBL240702

CCO.OCCS

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of 2-Mercaptoethanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116987775-A Proportioning detection method of multi-RNA mixture and application thereof 珠海丽凡达生物技术有限公司 2023-11-03 CN claimed
CN-112662732-A High-throughput rapid screening method of pantothenate synthetase mutants 浙江工业大学 2021-04-16 CN claimed
CN-106106473-A A kind of compositions preventing and treating Caulis et Folium Brassicae capitatae diamondback moth and preparation method thereof 殷佩琼 2016-11-16 CN claimed
EP-0185066-A1 UNIV PASTEUR 1986-06-25 EP claimed
WO-1986000304-A1 SULPHUR-CONTAINING DERIVATIVES OF PARA-METHOXYCINNAMIC ACID, PRODUCTION PROCESSES THEREOF, DERMO-PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND APPLICATIONS UNIVERSITE LOUIS PASTEUR (STRASBOURG I) (FR) 1986-01-16 WO claimed
CN-109593068-B Intermediate of ROR gamma inhibitor and preparation method thereof 广东东阳光药业有限公司 2022-12-27 CN disclosed
US-11325887-B2 Methods for forming peroxyformic acid and uses thereof ECOLAB USA INC. (US) 2022-05-10 US disclosed
CN-112662732-A High-throughput rapid screening method of pantothenate synthetase mutants 浙江工业大学 2021-04-16 CN disclosed
US-10899707-B2 Methods for forming peroxyformic acid and uses thereof ECOLAB USA INC. (US) 2021-01-26 US disclosed
US-20200157046-A1 METHODS FOR FORMING PEROXYFORMIC ACID AND USES THEREOF ECOLAB USA INC. 2020-05-21 US disclosed
US-20190152906-A1 METHODS FOR FORMING PEROXYFORMIC ACID AND USES THEREOF ECOLAB USA INC. 2019-05-23 US disclosed
CN-106106473-A A kind of compositions preventing and treating Caulis et Folium Brassicae capitatae diamondback moth and preparation method thereof 殷佩琼 2016-11-16 CN disclosed
US-20120003188-A1 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS, INC. (US) 2012-01-05 US disclosed
WO-2011150398-A1 COMPOSITIONS AND METHODS OF USING LIVING AND NON-LIVING BIOACTIVE DEVICES WITH COMPONENTS DERIVED FROM SELF- RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO GARNET BIOTHERAPEUTICS, INC (US) 2011-12-01 WO disclosed
EP-2171043-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO Garnet BioTherapeutics, Inc (US) 2010-04-07 EP disclosed
US-20090053183-A1 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro NEURONYX INC. (US) 2009-02-26 US disclosed
WO-2008156728-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO NEURONYX, INC. (US) 2008-12-24 WO disclosed
US-6566097-B2 Polypeptide for use in the treatment of mammalian viral diseases JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) 2003-05-20 US disclosed
US-20020107366-A1 Novel feline cytokine protein TAKARA SHUZO CO., LTD. (JP) 2002-08-08 US disclosed
US-5032506-A Color control system ENZYMATICS, INC. (US) 1991-07-16 US disclosed